The conference Moving Beyond, which took place at the Champalimaud Foundation on April 3 and 4, 2025, was organised to gather world scientific leaders in the field of “exercise oncology”.

During the two-day conference, we interviewed a series of invited speakers on the benefits of physical activity for cancer prevention and treatment and asked speakers to share some of the key scientific advances in exercise oncology.

Watch the video and hear what they had to say — we hope you enjoy it!

This recognition affirms the dedication and collaborative effort of countless individuals over the years in building the diverse and sophisticated infrastructure necessary to support a world-class, cutting-edge biomedical research centre.

This course is promoted by Champalimaud Foundation's Fior Lab.

The scientific programme will cover

- Protocols for preparation of human cancer cells for injection;
- Generation of zebrafish xenografts (microinjection in the perivitelline space);
- Metastatic assay;
- Protocols for immunofluorescence;
- Mounting xenografts for confocal imaging;
- Confocal session.

Venue

Champalimaud Center for the Unknown, Lisbon

Dates

30 June - 4 July, 2025 - 9:00

Application

Deadline: 9 May

This year, the conference will continue to explore the theme of Change, focusing on the need to discover, engage, and resolve. At a time when we have the privilege to make a difference, we aim to act and (r-)evolve.

In the morning session, we will introduce new areas of research and emerging frontiers in nursing practice, which can contribute to both our personal and professional development. In the afternoon, we will address the mental health of healthcare professionals and patients, with a special focus on managing anxiety in healthcare settings.

The Informatics Technology Department Unit at the Champalimaud Foundation in Lisbon, is looking for a Junior Data Manager dedicated to designing business intelligence processes and harmonising corporate, medical and research data for extraction of relevant metrics. It will be your job to liaise between the different branches of the institution.

At the Champalimaud Colorectal Cancer Conference, last February, Gina Brown, from the Imperial College London, questioned the validity of the current staging strategy for colon cancer. Indeed, research shows that lymph nodes are not the main culprit in colon cancer spread, and can actually be a sign that the patient’s immune system is fighting back.